A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25Paul Brennan, Lorenzo Simonato, James McKay et al.|Nature|2008Cited by 1.3k
First-Line Lorlatinib or Crizotinib in Advanced <i>ALK</i> -Positive Lung CancerAlice T. Shaw, Benjamin Solomon, Todd M. Bauer et al.|New England Journal of Medicine|2020Cited by 1.1k
Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancerCorina Lesseur, Devasena Anantharaman, Brenda Diergaarde et al.|Nature Genetics|2016Cited by 252
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 StudyMyung‐Ju Ahn, Jaafar Bennouna, Ines B. Menjak et al.|Journal of Clinical Oncology|2024Cited by 177
Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non–Small-Cell Lung CancerAlona Zer, Natasha B. Leighl, Preet Walia et al.|Clinical Lung Cancer|2018Cited by 144